Agilent delivers trusted answers and insights to advance the quality of life. Our laboratory instruments and technologies help scientists further disease research, develop advanced therapies, and ensure our water, food, air, and fuels are clean. The discoveries we enable make the world a better place to live.
Agilent serves large, attractive markets with a $68B opportunity, growing 4-6%
Agilent provides critical tools and capabilites that help our customers address some of humanity’s biggest challenges including disease detection and therapeutics, environmental health, and food safety.
*TAM = Total Available Market. Market size per Company estimates
Agilent has market leadership position in key analytical and diagnostic technologies
Gas and Liquid Chromatography Mass Spectrometry Atomic and Molecular Spectroscopy Cell Analysis Laboratory Management Software Chemistries and Consumables
CrossLab Services Lab Enterprise Services
Genomics Solutions Cancer Diagnostics Therapeutic Oligonucleotides
Agilent’s trusted measurements and workflow solutions enable customers in analytical, research and diagnostics laboratories achieve superior scientific and economic outcomes
We operate as one company, with one culture, and a set of core strategies
Provides innovative technology and workflow solutions with commercial models that address the most critical customer needs.
Operates as one-company to address key market requirements by coordinating software, hardware, consumables, and support capabilities companywide.
Continuous improvement culture with constant focus on productivity and efficiency enables prioritized investments and margin expansion.
Consistent track record in conducting business and managing risk in an ethical, socially responsible and environmentally sustainable manner.
Agilent represents a differentiated investment opportunity with a track record of consistent results
* Operating Margin & EPS presented on a non - GAAP basis, reconciliations to closest GAAP equivalent provided in financial summary.